Article

Iridex expands EndoProbe product line with stepped probes

Washington, DC &#8212 Iridex Corp. announced the addition of two new IRIS Medical Stepped EndoProbe handpieces to its existing line of disposable endophotocoagulation probes. The unique probe designs offer a smooth, gently tapered needle that permits the angled tip to be inserted through either standard 20- or 25-gauge cannulas for full coverage of the peripheral retina.

April 19 - Washington, DC - Iridex Corp. announced the addition of two new IRIS Medical Stepped EndoProbe handpieces to its existing line of disposable endophotocoagulation probes. The unique probe designs offer a smooth, gently tapered needle that permits the angled tip to be inserted through either standard 20- or 25-gauge cannulas for full coverage of the peripheral retina.

The endoprobes offer a rigid, fixed-angle alternative to flexible tip directional probes and will increase the endophotocoagulation options available to vitreoretinal surgeons.

There are two new Stepped EndoProbe models (both with patents pending): 20 to 24 gauge/45 degree angle and 25 to 30 gauge/45 degree angle.

EndoProbe handpieces are compatible with IRIS Medical OcuLight green (532 nm), OcuLight infrared (810 nm), and IQ 810 infrared laser photocoagulators as well as competitive laser systems that accept a universal SMA connector. The current EndoProbe product family includes 20 gauge: straight, passive aspirating, active aspirating, angled, and illuminating models; and 25-gauge straight.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.